Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nevis Brands Inc C.NEVI

Alternate Symbol(s):  NEVIF

Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include the flagship brand Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience with no cannabis taste or smell. Major offers various flavors, such as volcanic orange mango, sunset pink lemonade, Pacific Coast blue raspberry, dreamin' of passion, and sacred grape. It also offers Major Minis, which is a smaller 2 ounce (oz) shot. Major Minis come in three flavors, such as blueberry, fruit punch, and blackberry lemonade. The Company has introduced Major Mojo-Rita and Sugar-Free Ginger-ade in Washington and Major Sugar-Free Lemonade and Apple Peach in Missouri.


CSE:NEVI - Post by User

Post by Davidtepperss62on Aug 27, 2020 8:26am
209 Views
Post# 31459295

Pascal lists shares on Frankfurt exchange $$$$$$$$$$$$$$$$$$

Pascal lists shares on Frankfurt exchange $$$$$$$$$$$$$$$$$$

Dr. Patrick Gray reports

PASCAL BIOSCIENCES ANNOUNCES LISTING ON THE FRANKFURT STOCK EXCHANGE

Pascal Biosciences Inc.'s common shares were accepted for listing on the Frankfurt Stock Exchange under the trading symbol 6PB, ISIN: CA7024781089, WKN: A2DQU4. The company's common shares are now cross-listed on the TSX Venture Exchange and the FSE.

"We are very pleased to have Pascal shares listed on the Frankfurt Stock Exchange," said Dr. Patrick Gray, chief executive officer of Pascal. "This listing will offer a large number of new investors the opportunity to invest in Pascal, expanding our shareholder base and potentially increasing liquidity."

The Frankfurt Stock Exchange is one of the world's leading international stock exchanges by revenue, profitability and market capitalization. The FSE provides access to millions of international investors, and only Nasdaq and the New York Stock Exchanges are larger. An FSE listing is expected to increase trading liquidity, and can assist in attracting investment by institutional and retail investors in Europe.

About Pascal Biosciences Inc.

Pascal is a biotechnology company targeting innovative therapies for serious diseases, including COVID-19. Pascal is also developing treatments for cancer with targeted therapies for acute lymphoblastic leukemia and cannabinoid-based therapeutics.

<< Previous
Bullboard Posts
Next >>